BIBLIOGRAFIA 114

114

BIBLIOGRAFIA

Abdel-Aal AM. Ilizarov bone transport for massive tibial bone defects. Orthopedics2006; 29: 70-74. Ali SAM, Doherty PJ, Williams DF. Mechanisms of polymer degradation in implantable devices. 2.

Poly(dl-lactic acid). J Biomed Mater Res 1993; 27: 1409-1418.

Altman GH, Diaz F, Jakuba C, Calabro T, Horan RL, Chen J, Lu H, Richmond J, Kaplan DL. Silk-based biomaterials. Biomaterials 2003; 24: 401-416.

An YH, Friedman RJ. Animal Models of Bone Defect Repair. In: An YH, Friedman RJ. Animal models in Orthopaedic research. CRC Press 1999b; 13: 241-260.

An YH, Friedman RJ. Animal selection in orthopaedic research. In: An YH, Friedman RJ (eds.) Animal models in Orthopaedic research. CRC Press 1999a; 39-57.

Argintar E, Edwards S, Delahay J. Bone morphogenetic proteins in orthopaedic trauma surgery. Injury 2011; 42: 730-734.

Aronson J. Limb-lengthening, skeletal reconstruction, and bone transport with the Ilizarov method. J Bone Joint Surg Am 1997; 79: 1243-1258.

Bae S, Shoda M. Bacterial cellulose production by fed-batch fermentation in molasses medium. Biotechnol Prog 2004; 20: 1366-1371.

Balakrishnan S, Krishnan M, Dubois P, Narayan R. Kinetic and thermodynamic considerations in the synthesis of a new three-arm poly (ε-caprolactone). Polymer Eng Sci 2004; 44: 1491-1497. Balakrishnan S, Krishnan M, Narayan R, Dubois P. Three-arm poly (ε-caprolactone) by extrusion

polymerization. Polymer Eng Sci 2006; 46: 235-240.

Balmayor ER, Tuzlakoglu K, Azevedo HS, Reis RL. Preparation and characterization of starch-poly-ε- caprolactone microparticles incorporating bioactive agents for drugs delivery and tissue engineering applications. Acta Biomateralia 2009; 5: 1035-1045.

Barbarossa V, Matković BR, Vucić N, Bielen M, Gluhinić M. Treatment of Osteomyelitis and Infected Non‐union of the Femur by a Modified Ilizarov Technique: Follow‐up Study. CMJ 2001; 42: 634‐641.

Barbosa MA, Granja PL, Barrias CC, Amaral IF. Polysaccharides as scaffolds for bone regeneration. ITBM-RBM 2005; 26: 212-217.

Barton BF, Reeve JL, McHugh AJ. Observations on the dynamics of nonsolventinduced phase inversion. J Polym Sci Pol Phys 1997; 35: 569-585.

Bastioli C. Starch-polymer composites. In: Scott G, Gilead D (eds.) Degradable Polymers. London: Chapman & Hall 1995; 113-137.

Bates P, Ramachandran M. Bone injury, healing and grafting. In: Basic Orthopaedic Sciences. The Stanmore Guide. Ramachandran M. (Ed) London: Hodder Arnold 2007; 123-134.

Bauer TW, Muschler GF. Bone graft materials. An overview of the basic science. Clin Orthop Related Res 2000; 371: 10-27.

115

epsilon]-caprolactone) microparticles for oral vaccine delivery. Int J Pharm 1999; 184: 73–84.

Beretta C. Fluorochinoloni. In: Prescott JF, Demond Baggot J (eds.) Terapia antimicrobica in medicina Veterinaria. 1° Ed Italiana. 1996; 291-302.

Bibbo C, Bono CM, Lin SS. Union rates using autologous platelet concentrate alone and with bone graft in high-risk foot and ankle surgery patients. J Surg Orthop Adv 2005; 14: 17-22.

Bodde EWH, Spauwen PHM, Mikos AG, Jansen JA. Closing capacity of segmental radius defects in rabbits. J Biomed Mater Res A 2008; 85: 206-217.

Bos GD, Goldberg VM, Powell AE, Heiple KG, Zika JM. The effect of histocompatibility matching on canine frozen bone allografts. J Bone Joint Surg Am 1983; 65: 89-96.

Boyan BD, Hummert TW, Dean DD, Schwartz Z. Role of material surfaces in regulating bone and cartilage cell response. Biomaterials 1996; 17: 137-146.

Braden TD. Post traumatic osteomyelitis. Vet Clin North Am Small Anim Prac 1991; 21: 781-811. Brown SA. Fluoroquinolones in animal health. J Vet Pharmacol Ther 1996; 19: 1-14.

Bubenik LJ. Infections of the skeletal system. Vet Clin Small Anim 2005; 35: 1093-1109.

Buchholz HW, Elson RA, Heinart K. Antibiotic-loaded acrili cement: current concepts. Clin Orthop 1984; 190: 96-108.

Bucholz RW. Nonallograft osteoconductive bone graft substitutes. Clin Orthop 2002; 395: 44-52. Budsberg SC. Osteomielytis. In: Johnson AL, Houlton EF, Vannini R (eds.) AO Principles of Fracture

Management in the dog and cat. AO Publishig, Switzerland, 2005; 417- 423.

Calhoun JH, Mader JT. Treatment of osteomyelitis with a biodegradable antibiotic implant. Clin Orthop 1997; 341: 207-214.

Calvert JW, Weiss LE, Sundine MJ. New frontiers in bone tissue engineering. Clin Plast Surg 2003; 30: 641-648.

Cammisa FP Jr, Lowery G, Garfin SR, Geisler FH, Klara PM, McGuire RA, Sassard WR, Stubbs H, Block JE. Two-year fusion rate equivalency between Grafton DBM gel and autograft in posterolateral spine fusion: a prospective controlled trial employing side-by-side comparison in the same patient. Spine 2004; 29: 660-666.

Cariou M, Boulouis HJ, Moissonnier P. Inclusion of marbofloxacin in PMMA orthopaedic cement. An in vitro experimental study. Vet Comp Orthop Traumatol 2006; 2: 106-109.

Carter G. Harvesting and implanting allograft bone. AORN J 1999; 70: 660-670.

Castañeda S, Largo R, Calvo E, Rodríguez-Salvanés F, Marcos ME, Díaz-Curiel M, Herrero-Beaumont G. Bone mineral measurements of subchondral and trabecular bone in healthy and osteoporotic rabbits. Skeletal Radiol 2006; 35: 34-41.

Chang HI, Lau YC, Yan C, Coombes AG. Controlled release of an antibiotic, gentamicin sulphate, from gravity spun polycaprolactone fibers. J Biomed Mater Res A 2008; 84: 230-237.

Chapman MW, Bucholz R, Cornell C. Treatment of acute fractures with a collagen-calcium phosphate graft material: a randomized clinical trial. J Bone Joint Surg Am 1997; 79: 495-502.

116

Biomaterials 2005; 26: 6565-6578.

Chen RR, Mooney DJ. Polymeric growth factor delivery strategies for tissue engineering. Pharm Res 2003; 20: 1103-1112.

Chew SY, Dzenis Y, Leong KW, Wen Y. The Role of Electrospinning in the Emerging Field of Nanomedicine. Curr Pharm Des 2006; 12: 4751-4770.

Chou YF, Dunn JCY, Wu BM. In vitro response of MC3T3-E1 preosteoblasts within three-dimensional apatite-coated PLGA scaffolds. J Biomed Mater Res B 2005; 75: 81-90.

Chu PK, Chen JY, Wang LP, Huang N. Plasma-surface modification of biomaterials. Mater Sci Eng R 2002; 36: 143-206.

Constantino PD, Freidman CD. Synthetic bone graft substitutes. Otolaryngol Clin North Am 1994; 27: 1037-1073.

Coombes AGA, Rizzi SC, Williamson M, Barralet JE, Downes S, Wallace WA. Precipitation casting of polycaprolactone for applications in tissue engineering and drug delivery. Biomaterials 2004; 25: 315-325.

Crow BB, Nelson KD. Release of bovine serum albumin from a hydrogel-cored biodegradable polymer fiber. Biopolymers 2006; 81: 419-427.

Crow BB, Borneman AF, Hawkins DL, Smith GM, Nelson KD. Evaluation of in vitro drug release, pH change, and molecular weight degradation of poly(L-lactic acid) and poly(D,Llactide- co-glycolide) fibers. Tissue Eng 2005; 11: 1077-1084.

Cypher TJ, Grossman JP. Biological principles of bone graft healing. J Foot Ankle Surg 1996; 35: 413-417.

De Long WG Jr, Einhorn TA, Koval K, McKee M, Smith W, Sanders R, Watson T. Bone grafts and bone graft substitutes in orthopaedic trauma surgery. A critical analysis. J Bone Joint Surg Am 2007; 89: 649-658.

Deng M, Nair LS, Nukavarapu SP, Kumbar SG, Jiang T, Krogman NR, Singh A, Allcock HR, Laurencin CT. Miscibility and in vitro osteocompatibility of biodegradable blends of poly[(ethyl alanato) (p-phenyl phenoxy) phosphazene] and poly(lactic acid-glycolic acid). Biomaterials 2008; 29: 337-349.

Denkbas EB, Seyyal M, Piskin, E. Implantable 5-fluorouracil loaded chitosan scaffolds prepared by wet spinning, J Membr Sci 2000; 172: 33-38.

Diez-Pena E, Frutos G, Frutos P, Barrales-Rienda JM. Gentamicin sulphate release from modified commercial acrili surgical radiopaque bone cement, Part1: influence of the gentamicin concentration on the release process mechanism. Chem Pharm Bull 2002; 50: 1201-1208. Dimitriou R, Jones E, McGonagle D, Giannoudis PV. Bone regeneration: current concepts and future

directions. BMC Medicne 2011, 9: 66-75.

Dimitriou R, Tsiridis E, Giannoudis PV. Current concepts of molecular aspects of bone healing. Injury 2005; 36: 1392-1404.

Doi Y, Steinbüchel A. Polyesters I. Biological systems and biotechnological production. Weinheim: Wiley-VCH 2002.

117

defect healing: An update on a multi-component apporach. Injury 2008; 39: S9-S20.

Duval JM, Bundsberg SC. Cortical Bone concentration of enrofloxacin in dogs. Am J Vet Res 1995; 56: 188-192.

Einhorn TA, Lane JM, Burstein AH, Kopman CR, Vigorita VJ. The healing of segmental bone defects induced by demineralized bone matrix. A radiographic and biomechanical study. J Bone Joint Surg Am. 1984; 66: 274-279.

Einhorn TA. The cell and molecular biology of fracture healing. Clin Orthop Relat Res 1998; 355: S7-S21.

Elsinger EC, Leal L. Coralline hydroxyapatite bone graft substitutes. J Foot Ankle Surg 1996; 35: 396-399.

Engel E, Michiardi A, Navarro M, Lacroix D, PLanell JA. Nanotechnology in regenerative medicine: the materials side. Trends Biotechnol 2008; 26: 39-47.

Fabbri P, Bondioli F, Messori M, Bartoli C, Dinucci D, Chiellini F. Porous scaffolds of polycaprolactone reinforced with in situ generated hydroxyapatite for bone tissue engineering. J Mater Sci Mater Med 2010; 21: 343-351.

Fang B, Wan Y-Z, Tang T-T, Gao C, Dai K-R. Proliferation and osteoblastic differentiation ofhumanbone marrow stromal cells on hydroxyapatite/bacterial cellulose nanocomposite scaffolds. Tissue Eng A 2009; 15: 1091-1098.

Finkemeier CG. Bone-grafting and bone-graft substitutes. J Bone Joint Surg 2002; 84: 454-464. Fish DN, Chow AT. The clinical pharmacokinetics of levofloxacin. Clin Pharmacokin 1997; 32:

101-119.

Fleming JE Jr, Cornell CN, Muschler GF. Bone cells and matrices in orthopedic tissue engineering. Orthop Clin North Am 2000; 31: 357-374.

Freyman TM, Yannas IV, Gibson LJ. Cellular materials as porous scaffolds for tissue engineering. Prog Mat Sci 2001; 46: 273-282.

Friedlaender GE, Strong DM, Tomford W, Mankin HJ. Longterm follow-up of patients with osteochondral allografts. A correlation between immunologic responses and clinical outcome. Orthop Clin North Am 1999; 30: 583-588.

Gao H, Gu Y, Ping Q. The implantable 5-fluorouracil-loaded poly(l-lactic acid) fibers prepared by wet-spinning from suspension. J Control Release 2007; 118: 325–332.

Gatti AM, Valdre G, Oh A. Analysis of the in vivo reactions of a bioactive glass in soft and hard tissue. Biomaterials 1994; 15: 208–212.

Geiger F, Bertram H, Berger I, Lorenz H, Wall O, Eckhardt C, Simank HG, Rchter W. Vascular Endothelial Growth Factor Gene-Activated Matrix (VEGF165-GAM) Enhances Osteogenesis and Angiogenesis in Large Segmental Bone Defects. J Bone and Mineral Research 2005; 20: 2028-2035.

Ghosh K, Ren XD, Shu XZ, Prestwich GD, Clark RAF. Fibronectin functional domains coupled to hyaluronan stimulate adult human dermal fibroblast responses critical for wound healing. Tissue Eng 2006; 12: 601-613.

118

40: S1-S3.

Gil-Albarova J, Salinas AJ, Bueno-Lozano AL, Roman J, Aldini-Nicolo N, Garcia-Barea A, Giavaresi G, Fini M, Giar- Journal of Biomedical Materials Research Part A dino R, Vallet-Regi M. The in vivo behaviour of a sol–gel glass and a glass-ceramic during critical diaphyseal bone defects healing. Biomaterials 2005; 26: 4374–4382.

Gitelis S, Brebach GT. The treatment of chronic osteomyelitis with a biodegradable antibiotic-impregnated implant. J Orthop Surg 2002; 10: 53-60.

Goldberg VM, Stevenson S, Shaffer JW. Biology of autografts and allografts. In: Friedlander GE, Goldberg VM (eds). Bone and cartilage allografts: biology and clinical applications. Park Ridge, Illinois: The American Academy of Orthopaedic Surgeons 1991; 3-11.

Gomes ME, Bossano CM, Johnston CM, Reis RL, Mikos AG. In vitro localization of bone growth factors in constructs of biodegradable scaffolds seeded with marrow stromal cells and cultured in a flow perfusion bioreactor. Tissue Eng 2006; 12: 177-188.

Gomes ME, Godinho JS, Tchalamov D, Cunha AM, Reis RL. Alternative tissue engineering scaffolds based on starch: processing methodologies, morphology, degradation and mechanical properties. Mater Sci Eng C 2002; 20: 19-26.

Gomes ME, Malafaya P, Ribeiro A, Reis RL, Cunha AM. A new approach based on injection moulding to produce starch based biodegradable scaffolds: morphology, mechanical and degradation behaviour. Biomaterials 2000; 22: 883-889.

Gomes ME, Sikavitsas VI, Behravesh E, Reis RL, Mikos AG. Effect of flow perfusion on the osteogenic differentiation of bone marrow stromal cells cultured on starch-based three-dimensional scaffolds. J Biomed Mater Res A 2003; 67: 87-95.

Gorna K, Gogolewski S. Biodegradable porous polyurethane scaffolds for tissue repair and regeneration. J Biomed Mater Res A 2006; 79: 128-138.

Gorna K, Gogolewski S. Preparation, degradation, and calcification of biodegradable polyurethane foams for bone graft substitutes. J Biomed Mater Res A 2003; 67: 813-827.

Gosline JM, Demont ME, Denny MW. The structure and properties of spider silk. Endeavour 1986; 10: 37–43.

Green SA, Jackson JM, Wall DM, Marinow H, Ishkanian J. Management of segmental defects by the Ilizarov intercalary bone transport method. Clin Orthop Related Res 1992; 280: 136-142. Greish YE, Bender JD, Lakshmi S, Brown PW, Allcock HR, Laurencin CT. Composite formation from

hydroxyapatite with sodium and potassium salts of polyphosphazene. J Mater Sci Mater Med 2005; 16: 613-620.

Ham K, Griffon D, Seddighi M, Johnson AL. Clinical Application of Tobramycin-Impregnated Calcium Sulfate Beads in Six Dogs (2002-2004). J Am Anim Hosp Assoc 2008; 44: 320-326.

Hedberg EL, Kroese-Deutman HC, Shih CK, Crowther RS, Carney DH, Mikos AG, Jansen JA. In vivo degradation of porous poly(propylene fumarate)/poly(DL-lactic-co-glycolic acid) composite scaffolds. Biomaterials 2005a; 26: 4616-4623.

Hedberg EL, Kroese-Deutman HC, Shih CK, Lemoine JJ, Liebschner MAK, Miller MJ, Yasko AW, Crowther RS, Carney DH, Mikos AG, Jansen JA. Methods: A comparative analysis of

119

Hedlund CS. Neoplasie del cavo orale. In: Fossum T.W.: Chirurgia dei piccoli animali. II ed. Italiana, Masson, Milano 2004; 21: 291-296.

Heidemann W, Jeschkeit S, Ruffieux K, Fischer JH, Wagner M, Krüger G, Wintermantel E, Gerlach KL. Degradation of poly(d,l)lactide implants with or without addition of calciumphosphates in vivo. Biomaterials 2001; 22: 2371-2381.

Helenius G, Bäckdahl H, Bodin A, Nannmark U, Gatenholm P, Risberg B. In vivo biocompatibility of bacterial cellulose. J Biomed Mater Res A 2006; 76: 431-438.

Hench LL, Wilson J. An introduction to bioceramics. 2nd ed. London: Word Scientific 1999. Hench LL. Bioceramics: from concept to clinic. J Am Ceram Soc 1991; 74: 1487–1510.

Henry JA, Burugapalli K, Neuenschwander P, Pandit A. Structural variants of biodegradable polyesterurethane in vivo evoke a cellular and angiogenic response that is dictated by architecture. Acta Biomater 2009; 5: 29-42.

Henry SL, Gregory AH, Seligson D. Long-term implantation of gentamycin-polymethylmethacrylate antibiotic beads. Clin Orthop 1993; 295: 47-53.

Hernigou P, Poignard A, Beaujean F, Rouard H. Percutaneous autologous bone-marrow grafting for nonunions. Influence of the number and concentration of progenitor cells. J Bone Joint Surg Am 2005; 87: 1430-1437.

Holmes RE. Bone regeneration within a coralline hydroxyapatite implant. Plast Reconstr Surg 1979; 63: 626-633.

Holtom PD, Pavkovic SA, Bravos PD, Patzakis MJ, Shepherd LE, Frenkel B. Inhibitory effects of the quinolone antibiotics trovafloxacin, ciprofloxacin, and levofloxacin on osteoblastic cells in vitro. J Orthop Res 2000; 18: 721-727.

Horan RL, Antle K, Collette AL, Wang Y, Huang J, Moreau JE, Volloch V, Kaplan DL, Altman GH. In vitro degradation of silk fibroin. Biomaterials 2005; 26: 3385-3393.

Hu Q, Li B, Wang M, Shen J. Preparation and characterization of biodegradable chitosan/hydroxyapatite nanocomposite rods via in situ hybridization: a potential material as internal fixation of bone fracture. Biomaterials 2004; 25; 779-785.

Huang X, Brazel CS. On the importance and mechanisms of burst release in matrix.controlled drug delivery systems. J Control Release 2001; 73: 121-136.

Huddleston PM, Steckelberg JM, Hanssen AD, Rouse MS, Bolander ME, Patel R. Ciprofloxacin inhibition of experimental fracture-healing. J Bone Joint Surg Am 2000; 82: 161-173.

Huibregtse BA, Johnstone B, Goldberg VM, Caplan AI. Effect of age and sampling site on the chondro-osteogenic potential of rabbit marrowderived mesenchymal progenitor cells. J Orthop Res 2000; 18: 18-24.

Hutmacher DW. Scaffold design and fabrication technologies for engineering tissues – state of the art and future perspectives, J Biomater Sci Polymer Ed 2001; 12: 107-124.

120

Jabbarzadeh E, Starnes T, Khan YM, Jiang T, Wirtel A, Deng M, Lv Q, Nair Ls, Doty SB, Laurencin CT. Induction of angiogenesis in tissue-engineered scaffolds designed for bone repair: A combined gene therapy–cell transplantation approach. PNAS 2008; 105: 11099-11104. Jackson LC, Pacchiana PD. Common complications of fracture repair. Clin Tech Small Anim Pract

2004; 19: 168-179.

Jäger M, Herten M, Fochtmann U, Fischer J, Hernigou P, Zilkens C, Hendrich C, Krauspe R. Bridging the gap: bone marrow aspiration concentrate reduces autologous bone grafting in osseous defects. J Orthop Res 2011; 29: 173-180.

Jin H-J, Chen J, Karageorgiou V, Altman GH, Kaplan DL. Human bone marrow stromal cell responses on electrospun silk fibroin mats. Biomaterials 2004; 25: 1039–1047.

Johnson AL, Hulse DA. Fondamenti di chirurgia ortopedica e di trattamento delle fratture. In: Fossum TW. Chirurgia dei piccoli animali. II ed. Italiana, Masson, Milano 2004; 820-898.

Johnson KA. Osteomyelitis in dogs and cats. J Am Vet Med Assoc 1994; 205: 1882-1887.

Jones JR, Ehrenfried LM, Hench LL. Optimising bioactive glass scaffolds for bone tissue engineering. Biomaterials 2006; 27: 964–973.

Joosten U, Joist A, Frebel T, Brandth B, Diederihs S, von Eiff C. Evaluation of an in situ setting injectable calcium phosphate as a new carrier material for gentamicin in the treatment of chronic osteomyelitis: Studies in vitro and in vivo. Biomaterials 2004; 25: 4287–4295. Kanellakopoulou K, Thivaios GC, Kolia M, Dontas I, Nakopoulou L, Dounis E, Giamarellos-Bourboulis

EJ, Andreopoulos A, Karagiannakos P, Giamarellou H. Local Treatment of Experimental

Pseudomonas aeruginosa Osteomyelitis with a Biodegradable Dilactide Polymer Releasing

Ciprofloxacin. Antimicr Agent Chemother 2008; 52: 2335-2339.

Kanellakopoulou K, Giamarellos-Bourboulis EJ. Carrier system for the local delivery of antibiotics in bone infections. Drugs 2000; 59: 1223-1232.

Karageorgiou V, Kaplan D. Porosity of 3D biomaterial scaffolds and osteogenesis. Biomaterials 2005; 26: 5474-5491.

Kasten P, Vogel J, Geiger F, Niemeyer P, Luginbühl R, Szaly K. The effect of platelet-rich plasma on healing in critical-size long-bone defects. Biomaterials 2008; 29: 3983-3992.

Keating JF, McQueen MM. Substitutes for autologous bone graft in orthopaedic trauma. J Bone Joint Surg Br 2001; 83: 3-8.

Khan Y, Yaszemski MJ, Mikos AG, Laurencin CT. Tissue Engineering of Bone: Material and Matrix Consideration. J Bone Joint Surg Am 2008; 90 :36-42 d doi:10.2106/JBJS.G.01260

Kim BS, Mooney DJ. Development of biocompatible synthetic extracellular matrices for tissue engineering. Trends Biotechnol 1998; 16: 224-230.

Kim JH, Lee KH. Effect of PEG additive on membrane formation by phase inversion. J Memb Sci 1998; 138: 153–163.

Kinnunen I, Aitasalo K, Pollonen M, Varpula M. Reconstruction of orbital floor fractures using bioactive glass. J Craniomaxillofac Surg 2000; 28: 229-234.

121

Kohn J, Langer R. Bioresorbable and bioerodible materials. In: Ratner BD, Hoffman AS, Schoen FJ, Lemons JE (eds.) Biomaterials science: an introduction to materials in medicine. New York: Academic Press 1996; 64-72.

Lane JM, Sandhu HS. Current Approaches to Experimental Bone Grafting. Orthop Clin North Am 1987; 18: 213-225.

Lane JM, Tomin E, Bostrom MP. Biosynthetic bone grafting. Clin Orthop Related Res 1999; 367: S107–S117.

Laurencin CT, El-Amin SF, Ibim SE, Willoughby DA, Attawia M, Allcock HR, Ambrosio AA. A highly porous 3-dimensional polyphosphazene polymer matrix for skeletal tissue regeneration. J Biomed Mater Res 1996; 30: 133-138.

Lautenschlager EP, Jacobs JJ, Marshall GW, Meyer PR Jr. Mechanical properties of bone cements containing large doses of antibiotics powders. J Biomed Res 1976; 6: 929-938.

Leathers TD. Dextran. In: Steinbüchel A, (ed.) Biopolymers, vol. 5. Weinheim: Wiley-VCH 2002; 300– 321.

Lee CH, Singla A, Lee Y. Biomedical applications of collagen. Int J Pharm 2001; 221: 1-22.

LeGeros RZ, LeGeros JP. Calcium phosphate biomaterials: preparation, properties, and biodegradation. In: Wise DL, Trantolo DJ, Altobelli DE, Yaszemski MJ, Gresser JD, Schwartz ER, (eds.) Encyclopedia handbook of biomaterials and bioengineering part A: materials, vol. 2. New York: Marcel Dekker 1995; 1429-1463.

Lei Y, Rai B, Ho KH, Teoh SH. In vitro degradation of novel bioactive polycaprolactone—tricalcium phosphate composite scaffolds for bone engineering. Mat Sci Eng C 2007; 27: 293-298. Leong KF, Cheah CM, Chua CK. Solid freeform fabrication of threedimensional scaffolds for

engineering replacement tissues and organs. Biomaterials 2003; 24: 2363-2378.

Lévesque SG, Lim RM, Shoichet MS. Macroporous interconnected dextran scaffolds of controlled porosity for tissue-engineering applications. Biomaterials 2005; 26: 7436-7446.

Li C, Vepari C, Jina H-J, Kim HJ, Kaplan DL. Electrospun silk-BMP-2 scaffolds for bone tissue engineering. Biomaterials 2006; 27: 3115-3124.

Lin SS, Ueng SW, Liu SJ, Chan EC, Chao EK, Tsai CH, Chen KT, Wei FC, Shih CH. Development of a biodegradable antibiotic delivery system. Clin Orthop Relat Res 1999; 362: 240-250.

Littlewood R. The Benefits and Risks Of The Ilizarov Technique For Limb Reconstruction. 2011 On line

http://www.noc.nhs.uk/limbreconstruction/documents/articlewrittenbyrebeccalittlewood workexp.pdf (accessed April 19/2012)

Liu Y, Chan-Park MB. A biomimetic hydrogel based on methacrylated dextran-graft-lysine and gelatin for 3D smooth muscle cell culture. Biomaterials 2010; 31: 1158-1170 doi:10.1016/j.biomaterials. 2009.10.040.

Liu Y, Lu Y, Tian X, Cui G, Zhao Y, Yang Q, Yu S, Xing G, Zhang B. Segmental bone regeneration using an rhBMP-2-loaded gelatin/nonhydroxyapatite/fibrin scaffold in a rabbit model. Biomaterials 2009; 30: 6276-6285.

122

184-198.

Mack BC, Wright KW, Davis M. A biodegradable filament for controlled drug delivery. J Control Rel 2009; 139: 205-211.

Mäkinen TJ, Veiranto M, Lankinen P, Moritz N, Jalava J, Törmälä P, Aro HT. In vitro and in vivo release of ciprofloxacin from osteoconductive bone defect filler. J Antimicrob Chemother 2005; 56: 1063-1068.

Marler JJ, Upton J, Langer R, Vacanti JP. Transplantation of cells in matrices for tissue regeneration. Adv Drug Del Rev 1998; 33: 165-182.

Martin C, Winet H, Bao JY. Acidity near eroding polylactidepolyglycolide in vitro and in vivo in rabbit tibial bone chambers. Biomaterials 1996; 17: 2373-2380.

Marx RE, Carlson ER, Eichstaedt RM, Schimmele SR, Strauss JE, Georgeoff KR. Platelet-rich plasma: growth factor enhancement for bone grafts. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1998; 85: 638-646.

Mason RM, Crossman MV, Sweeney C. In: Laurent TC (ed.) The biology of hyaluronan. New York: Wiley 1989; 107-121.

May C. Management of bacterial osteomyelitis in dogs and cats. In Practice 2002; 6: 330-337. McClary KB, Ugarova T, Grainger DW. Modulating fibroblast adhesion, spreading, and proliferation

using self-assembled monolayer films of alkylthiolates on gold. J Biomed Mater Res 2000; 50: 428-439.

McGonagle D, English A, Jones EA. The relevance of mesenchymal stem cells in vivo for future orthopaedic strategies aimed at fracture repair. Curr Orthop 2007; 21: 262-267.

McKee MD, Wild LM, Schemitsch EH, Waddell JP. The use of an antibiotic- impregnated, osteoconductive, bioabsorbable bone substitute in the treatment of infected long bone defects: early results of a prospective trial. J Orthop Trauma 2002; 16: 622-627.

Meinig RP. Polylactide membranes in the treatment of segmental diaphyseal defects: Animal model experiments in the rabbit radius, sheep tibia, Yucatan minipig radius, and goat tibia. Injury 2002; 33: B58–B65.

Mendel V, Simanowski HJ, Scholz HC, Heymann H. Therapy with gentamicin-PMMA beads, gentamicin-collagen sponge, and cefazolin for experimental osteomyelitis due to Staphylococcus aureus in rats Arch Orthop Trauma Surg 2005; 125: 363–368.

Meyer U, Buchter A, Wiesmann H P, Joos U, Jones DB. Basic reactions of osteoblasts on structured material surfaces. Eur Cell Mat 2005; 9: 39-49.

Möller S, Weisser J, Bischoff S, Schnabelrauch M. Dextran and hyaluronan methacrylate based hydrogels as matrices for soft tissue reconstruction. Biomol Eng 2007; 24: 496-504.

Mondrinos MJ, Dembzynski R, Lu L, Byrapogu VKC, Wootton DM, Lelkes PI, Zhou J. Porogen-based solid freeform fabrication of polycaprolactone–calcium phosphate scaffolds for tissue engineering. Biomaterials 2006; 27: 4399-4408.

Muir P, Johnson KA. Anaerobic bacteria isolated from osteomyelitis in dogs and cats. Vet Surg 1992; 6: 463-466.

123

Muzzarelli RA, Mattioli-Belmonte M, Tietz C, Biagini R, Ferioli G, Brunelli MA, Fini M, Giardino R, Ilari P, Biagini G. Stimulatory effect on bone formation exerted by a modified chitosan. Biomaterials 1994; 15: 1075-1081.

Nauth A, Giannoudis PV, Einhorn TA, Hankenson KD, Friedlaender GE, Li R, Schemitsch EH. Growth factors: beyond bone morphogenetic proteins. J Orthop Trauma 2010; 24: 543-546.

Newman-Gage H. Banca d’osso per gli innesti allogenici: aggiornamenti su teorie e impieghi. In: Bojrab MJ, Ellison GW, Slocum B (eds). Tecnica Chirurgica 2- Chirurgia ortopedico-traumatologica: rachide, scheletro appendicolare. UTET Torino 2001; 858-861.

Nie L, Nicolau DP, Nightingale CH, Browner BC, Quintiliani R. In vitro elution of ofloxacin from a bioabsorbable polymer. Acta Orthop Scand 1995; 66: 365-368.

Niemeyer P, Szalay K, Luginbühl R, Südkamp NP, Kasten P. Transplantation of human mesenchymal stem cells in a non-autogenous setting for bone regeneration in a rabbit critical-size defect model. Acta Biomateralia 2010; 6: 900-908.

O’Driscoll SW, Saris DB, Ito Y, Fitzimmons JS. The chondrogenic potential of periosteum decreases with age. J Orthop Res 2001; 19: 95–103.

O’Driscoll SW. Articular cartilage regeneration using periosteum. Clin Orthop Relat Res 1999; 367: S186–S203.

Papich MG, Riviere JE. Fluoroquinolone antimicrobial drugs. In: Riviere JE, Papich MG, Adams HR (eds.) Veterinary Pharmacology and Therapeutics. Ninth ed. Wiley-Blackwell 2009; 983-1011.

Parker RB. Treatment of Post-traumatic osteomyelitis. Orthopedic Salvage Procedures. Vet Clin North Am Small Anim Pract 1987; 17: 841-856.

Pearce AI, Richards RG, Milz S, Schneider E, Pearce SG. Animal models for implant biomaterial research in bone: a review. Eur Cell Mat 2007; 13: 1-10.

Peltola M, Suonpää J, Aitasalo K, Määttänen H, Andersson O, Yli-Urpo A, Laippala P. Experimental followup model for clinical frontal sinus obliteration with bioactive glass. Acta Otolaryngol Suppl 2000; 543: 167-169.

Perry AC, Prpa B, Rouse MS, Piper KE, Hanssen AD, Steckelberg JM, Patel R. Levofloxacin and trovafloxacin inhibition of experimental fracture-healing. Clin Orthop Relat Res 2003; 414: 95-100.

Perry CR, Davenport K, Vossen MK. Local delivery of antibiotics via an implantable pump in the treatment of osteomyelitis. Clin Orthop 1988; 226: 222-230.

Peter SJ, Lu L, Kim DJ, Stamatas GN, Miller MJ, Yaszemski MJ, Mikos AG. Effects of transforming growth factor beta1 released from biodegradable polymer microparticles on marrow stromal osteoblasts cultured on poly(propylene fumarate) substrates. J Biomed Mater Res 2000; 50: 452-462.

Peter SJ, Nolley JA, Widmer MS, Merwin JE, Yaszemski MJ, Yasko AW, Engel PS, Mikos AG. In vitro degradation of a poly(propylene fumarate)/btricalcium phosphate composite orthopaedic scaffold. Tissue Eng 1997; 3: 207-215.

124

polymers as drug delivery systems. New York: Dekker 1990; 71-119.

Place ES, George JH, Williams CK, Stevens MM. Synthetic polymer scaffolds for tissue engineering. Chem Soc Rev 2009; 38: 1139-1151.

Probst A, Spiegel HU. Cellular mechanisms of bone repair. J Invest Surg 1997; 10: 77–86.

Porter JR, Henson A, Popat KC. Biodegradable poly(ε- caprolactone) nanowires for bone tissue engineering applications. Biomaterials 2009; 30: 780-788.

Puppi D, Chiellini F, Piras AM, Chiellini E. Polymeric Materials for Bone and Cartilage Repair. Progr Polymer Scie 2010a; 35: 403-440.

Puppi D, Detta N, Piras AM, Chiellini F, Clarke DA, Reilly GC, Chiellini E. Development of electrospun three-arm star poly(ε-caprolactone) meshes for tissue engineering applications. Macromol Biosci 2010b; 10: 887-897.

Puppi D, Piras AM, Chiellini F, Chiellini E, Martins A, Leonor IB, Neves N, Reis R. Optimized electro and wet-spinning techniques for the production of polymeric fibrous scaffolds loaded with bisphosphonate and hydroxyapatite. J Tissue Eng Regn Med 2011; 5: 253-263.

Puppi D, Piras AM, Detta N, Dinucci D, Chiellini F. Poly(lactic-co-glycolic acid) electrospun fibrous meshes for the controlled release of retinoic acid. Acta Biomater 2010c; 6: 1258-1268. Reuvers, AJ, Smolders, CA. Formation of membranes by means of immersion precipitation: Part II.

The mechanism of formation of membranes prepared from the system cellulose acetate-acetone-water. J Membr Sci 1987; 34: 67-86.

Rezwan K, Chen QZ, Blaker JJ, Boccaccini AR. Biodegradable and bioactive porous polymer/inorganic composite scaffolds for bone tissue engineering. Biomaterials 2006; 27: 3413-3431.

Rochat MC. Preventing treating osteomyelitis. Vet med 2001; 96: 678-685.

Roether JA, Gough JE, Boccaccini AR, Hench LL, Maquet V, Jerome R. Novel bioresorbable and bioactive composites based on bioactive glass and polylactide foams for bone tissue engineering. J Mater Sci Mater Med 2002; 13: 1207-1214.

Rout PGJ, Tarrant SF, Frame JW, Davies JE. Interaction between primary bone cell cultures and biomaterials. Part 3: a comparison of dense and macroporous hydroxyapatite. In: Pizzoferratto ARP, Lee AJC (eds.) Bioceramics and clinical applications. Amsterdam: Elsevier 1988; 591-596.

Salgado AJ, Coutinho OP, Reis RL, Davies JE. In vivo response to starch-based scaffolds designed for bone tissue engineering applications. J Biomed Mater Res A 2007; 80: 983-989.

Sandhu HS, Grewal HS, Parvataneni H. Bone grafting for spinal fusion. Orthop Clin North Am 1999; 30: 685-698.

Sassard WR, Eidman DK, Gray PM, Block JE, Russo R, Russell JL, Taboada EM. Augmenting local bone with Grafton demineralised bone matrix for posterolateral lumbar spine fusion: avoiding second site autologous bone harvest. Orthopedics 2000; 23: 1059-1065.

Savarino L, Baldini N, Greco M, Capitani O, Pinna S, Valentini S, Lombardo B, Esposito MT, Pastore L, Ambrosio L, Battista S, Causa F, Zeppetelli S, Guarino V, Netti PA. The performance of poly-e-caprolactone scaffolds in a rabbit femur model with and without autologous stromal cells and BMP4. Biomaterials 2007; 28: 3101-3109.

125

Contin Educ Pract Vet 2003; 25: 788-794.

Schellauf F, Grillo Fernandes E, Braunegg G, Chiellini E. Properties of PHAs and their correlation to fermentation conditions in biorelated polymers. In: Chiellini E, Gil H, Braunegg G, Buchert J, Gatenholm P, van der Zee M (eds.) Sustainable polymer science and technology. New York: Kluwer Academic/Plenum Publishers 2001; 115-124.

Schmidhammer R, Zandieh S, Mittermayr R, Linda E, Pelinka LE, Leixnering M, Hopf R, Kroepfl A, Redl H. Assessment of bone union/nonunion in an experimental model using microcomputed technology. J Trauma 2006; 61: 199-205.

Schmidt C, Wenz R, Nies B, Moll F. Antibiotic in vivo in vitro release histocompatibility and biodegradation of gentamicin implants based on lactic acid polymers and copolymers. J Control Rel 1995; 37: 83-94.

Schmitz JP, Hollinger JO. The critical size defect as an experimental model for craniomandibulofacial nonunions. Clin Orthop Relat Res 1986; 205: 299–308.

Schulz K. “Altre patologie ossee articolari”, In: Fossum TW. Chirurgia dei piccoli animali. III ed. Italiana, Masson, Milano 2008; 35: 1372-1395.

Setterstrom JA, Tice TR, Myers WE. Development of Encapusalated Antibiotics for Topical administration to wounds. In Kim SW (ed.) Recent advances in Drug Delivery Sistems. New York, Plenum 1984; 185-198.

Shen H, Hu X, Yang F, Bei J, Wang S. The bioactivity of rhBMP- 2 immobilized poly(lactide-co-glycolide) scaffolds. Biomaterials 2009; 30: 3150-3157.

Shin H, Jo S, Mikos AG. Biomimetic materials for tissue engineering. Biomaterials 2003; 24: 4353-4364.

Simon TM, Van Sickle DC, Kunishima DH, Jackson DW. Cambium cell stimulation from surgical release of the periosteum. J Orthop Res 2003; 21: 470–480.

Simpson AH, Mills L, Noble B. The role of growth factors and related agents in accelerating fracture healing. J Bone Joint Surg Br 2006; 88: 701-705.

Sinibaldi KR. Principi di innesto osseo. In: Bojrab MJ, Ellison GW, Slocum B (eds.) Tecnica Chirurgica 2- Chirurgia ortopedico-traumatologica: rachide, scheletro appendicolare. UTET Torino 2001; 49: 849-853.

Smith CW, Schiller AG, Smith AR, Dorner JL. Osteomyelitis in the dog: a retrospective study. J Am Hosp Assoc 1978; 14: 589-592.

Song HR, Cho SH, Koo KH, Jeong ST, Park YJ, Ko JH. Tibial bone defects treated by internal bone transport using the Ilizarov method. Int Orthop (SICOT) 1998; 22: 293–297.

Soontornvipart K, Necas A, Dvorak M. Effects of Metallic Implant on the Risk of Bacterial Osteomyelitis in Small Animals. Acta Vet Brno 2003; 72: 235-247.

Sopyan I, Mel M, Ramesh S, Khalid KA. Porous hydroxyapatite for artificial bone applications. Science and Technology of Advanced Materials 2007; 8: 116-123.

Soucacos PN, Johnson EO, Babis G. An update on recent advances in bone regeneration. Injury 2008; 39: S1-S4.

126

Desalination 1975; 16: 179-203.

Street J, Bao M, deGuzman L, Bunting S, Peale FV Jr, Ferrara N, Steinmetz H, Hoeffel J, Cleland JL, Daugherty A, van Bruggen N, Redmond HP, Carano RA, Filvaroff EH. Vascular endothelial growth factor stimulates bone repair by promoting angiogenesis and bone turnover. Proc Natl Acad Sci USA 2002; 99: 9656-9661.

Summers BN, Eisenstein SM. Donor site pain from the ilium: a complication of lumbar spine fusion. J Bone Joint Surg Br 1989; 71: 677—680.

Sung H-J, Meredith C, Johnson C, Galis ZS. The effect of scaffold degradation rate on three-dimensional cell growth and angiogenesis. Biomaterials 2004; 25: 5735-5742.

Taddei P, Tinti A, Reggiani M, Fagnano C. In vitro mineralization of bioresorbable poly([epsilon]-caprolactone)/apatite composites for bone tissue engineering: a vibrational and thermal investigation. J Mol Struct 2005; 744–747: 135-143.

Tatsuyama K, Maezawa Y, Baba H, Imamura Y, Fukuda M. Expression of various growth factors for cell proliferation and cytodifferentiation during fracture repair of bone. Eur J Histochem 2000; 44: 269-278.

Tessmar JK, Göpferich AM. Matrices and scaffolds for protein delivery in tissue engineering. Adv Drug Deliver Rev 2007; 59: 274-291.

Tsay CS McHugh AJ. A rationale for structure formation during phase inversion. J Polym Sci Pol Phys 1992; 30: 309-313.

Tsay CS McHugh AJ. Mass transfer modeling of asymmetric membrane formation by phase inversion. J Polym Sci Pol Phys 1990; 28: 1327-1365.

Tuzlakoglu K, Alves CM, Mano JF, Reis RL. Production and characterization of chitosan fibers and 3-D fiber mesh scaffolds for tissue engineering applications. Macromol Biosci 2004; 4: 811–819. Tuzlakoglu K, Pashkuleva I, Rodrigues MT, Gomes ME, van Lenthe GH, Müller R, Reis RL. A new route

to produce starch-based fiber mesh scaffolds by wet spinning and subsequent surface modification as a way to improve cell attachment and proliferation. J Biomed Mater Res A 2010; 92: 369–377.

Ural E, Kesenci K, Fambri L, Migliaresi C, Piskin E. Poly(D,L-lactide/ε-caprolactone)/ hydroxyapatite composites as bone filler: Preparation and characterization. Biomaterials 2000; 21: 2147-2154.

Vacanti JP, Morse MA, Saltzman WM, Domb AJ, Peter-Atayde A, Langer R. Selective cell transplantation using bioabsorbable artificial polymers as matrices. J Pediatr Surg 1998; 23: 3–9.

Wang G, Yang H, Li M, Lu S, Chen X, Cai X. The use of silk fibroin/hydroxyapatite composite co-cultured with rabbit bone-marrow stromal cells in the healing of a segmental bone defect. J Bone Joint Surg Br 2010; 92: 320-325.

Wang GH, Liu SJ, Ueng SWN, Chan EC. The release of cefazolin and gentamicin from biodegradable PLA/PGA beads. Int J Pharm 2004; 273: 203–212.

Wang X, Mabrey JD, Agrawal CM. An interspecies comparison of bone fracture properties. Biomed Mater Eng 1998; 8: 1-9.

127

2006; 17: 89-106.

Weese JS. A Review of multidrug resistant surgical site infections. Vet Comp Orthop Traumatol 2008; 21: 1-7.

Welch AB. Antibiotics in Acrylic bone cement ‘in vitro’ studies. J Biomed Mater Res 1978; 12: 679-700.

Wheeler DL, Chamberland DL, Schmitt JM, Buck DC, Brekke JH, Hollinger JO, Joh SP, Suh KW. Radiomorphometry and biomechanical assessment of recombinant human bone morphogenetic protein 2 and polymer in rabbit radius ostectomy model. J Biomed Mater Res 1998; 43: 365-373.

Wiedel JD. Salvage of infected total knee fusion: the last option. Clin Orthop 2002; 404: 139-142. Wienk IM, Boom RM, Beerlage MAM, Bulte AMW, Smolders CA, Strathmann H. Recent advances in

the formation of phase inversion membranes made from amorphous or semi-crystalline polymers. J Memb Sci 1996; 113: 361-371.

Wildermuth EB, Griffin CE, Rosenkrantz WS, Boord MJ. Susceptibility of Pseudomonas Isolates from the Ears and Skin of Dogs to Enrofloxacin, Marbofloxacin, and Ciprofloxacin. J Am Anim Hosp Assoc 2007; 43: 337-341.

Xynos ID, Edgar AJ, Buttery LDK, Hench LL, Polak JM. Ionic products of bioactive glass dissolution increase proliferation of human osteoblasts and induce insulin-like growth factor II mRNA expression and protein synthesis. Biochem Biophys Res Commun 2000; 276: 461-465. Xynos ID, Edgar AJ, Buttery LDK, Hench LL, Polak M. Gene expression profiling of human osteoblasts

following treatment with the ionic products of Bioglass 45S5 dissolution. J Biomed Mater Res 2001; 55: 151-157.

Yannas IV. Natural materials. In: Ratner BD, HoffmanAS, Schoen FJ, Lemons JE (eds). Biomaterials Science. An introduction to materials in medicine. California, USA: Academic Press 1996; 84-94.

Yilgor P, Tuzlakoglu K, Reis RL, Hasirci N, Hasirci V. Incorporation of a sequential BMP-2/BMP-7 delivery system into chitosan-based scaffolds for bone tissue engineering. Biomaterials 2009; 30: 3551-3559.

Zerwekh JE, Kourosh S, Scheinberg R, Kitano T, Edwards ML, Shin D, Selby DK. Fibrillar collagenbiphasic calcium phosphate composite as a bone graft substitute for spinal fusion. J Orthop Res 1992; 10: 562-572.